Copyright
©The Author(s) 2018.
World J Transplantation. Sep 10, 2018; 8(5): 188-197
Published online Sep 10, 2018. doi: 10.5500/wjt.v8.i5.188
Published online Sep 10, 2018. doi: 10.5500/wjt.v8.i5.188
N = 66 | Model 1Standardized coefficient Beta [95% CI] | P-value | Model 2Standardized coefficient Beta [95% CI] | P-value |
O2 pulse (mL/beat) | 0.707 [0.075, 0.104] | < 0.001 | 0.675 [0.069, 0.102] | < 0.001 |
HRreserve (beats/min) | 0.382 [0.007, 0.013] | < 0.001 | 0.397 [0.008, 0.013] | < 0.001 |
Muscular exercise capacity (Joule) | 0.162 [1.1E-5, 7.1E-5] | 0.008 | 0.155 [8.0-5, 7.1-5] | 0.015 |
BMI (kg/m2) | 0.067 [-0.004, 0.020] | 0.211 | ||
Sex | -0.029 [-0.142, 0.086] | 0.630 | ||
Age (yr) | 0.019 [-0.003, 0.004] | 0.719 | ||
Adjusted R2 | 0.85 | 0.84 |
- Citation: Rolid K, Andreassen AK, Yardley M, Bjørkelund E, Karason K, Wigh JP, Dall CH, Gustafsson F, Gullestad L, Nytrøen K. Clinical features and determinants of VO2peak in de novo heart transplant recipients. World J Transplantation 2018; 8(5): 188-197
- URL: https://www.wjgnet.com/2220-3230/full/v8/i5/188.htm
- DOI: https://dx.doi.org/10.5500/wjt.v8.i5.188